Common brand names for GLP-1 drugs include Wegovy, Ozempic, Zepbound, and Trulicity
Sustainable Healthcare: With global costs for chronic diseases expected to soar to $15.9 trillion by 2050 , scaling access to this medicine offers a path toward more sustainable public finances
A new study published on December 11 in medRxiv found that Ozempic and Wegovy medications may double the risk of a rare eye condition called non-arteritic anterior ischemic optic neuropathy (NAION)
District Court Judge Sim Lake dismissed the federal trademark law claims because Eli Lilly did not show it lost sales or suffered "irreparable harm" from Empower's allegedly false advertising
In preclinical animal studies, BPC 157 has shown a very high safety profile with no significant adverse effects reported
48 The brain has its lymphatic drainage system, in which the CSF plays a primary role